MELISSA MOSCZCZYNSKI: Open Payments
NPI 1508360538 · HORSHAM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 27 payments from 9 companies in 2025. Trend: 2023 $866 · 2024 $638 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $149 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Sage Therapeutics, LLC | 4 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $77 |
| Exeltis, USA Inc. | 3 | $58 |
| Evofem Biosciences, Inc. | 1 | $18 |
| MILLICENT US INC | 1 | $18 |
| CooperSurgical, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: INJECTAFER, ZURZUVAE, MYFEMBREE, SLYND, Phexxi, INTRAROSA, Paragard T 380A, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
